254 related articles for article (PubMed ID: 12552996)
1. Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis.
Geier D; Hebert B; Potti A
Anticancer Res; 2002; 22(6B):3797-9. PubMed ID: 12552996
[TBL] [Abstract][Full Text] [Related]
2. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
3. The association between malignant melanoma and noncutaneous malignancies.
Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
[TBL] [Abstract][Full Text] [Related]
4. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases.
Bradbear RA; Bain C; Siskind V; Schofield FD; Webb S; Axelsen EM; Halliday JW; Bassett ML; Powell LW
J Natl Cancer Inst; 1985 Jul; 75(1):81-4. PubMed ID: 2989605
[TBL] [Abstract][Full Text] [Related]
5. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver disease.
Fracanzani AL; Conte D; Fraquelli M; Taioli E; Mattioli M; Losco A; Fargion S
Hepatology; 2001 Mar; 33(3):647-51. PubMed ID: 11230745
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma associated with hereditary hemochromatosis occurring in non-cirrhotic liver.
von Delius S; Lersch C; Schulte-Frohlinde E; Fend F; Dobritz M; Schmid RM; Eckel F
Z Gastroenterol; 2006 Jan; 44(1):39-42. PubMed ID: 16397838
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatic iron overload and association with hepatocellular cancer in end-stage liver disease: results from the National Hemochromatosis Transplant Registry.
Ko C; Siddaiah N; Berger J; Gish R; Brandhagen D; Sterling RK; Cotler SJ; Fontana RJ; McCashland TM; Han SH; Gordon FD; Schilsky ML; Kowdley KV
Liver Int; 2007 Dec; 27(10):1394-401. PubMed ID: 17927713
[TBL] [Abstract][Full Text] [Related]
8. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
9. Multiple primary malignancies in renal cell carcinoma.
Rabbani F; Grimaldi G; Russo P
J Urol; 1998 Oct; 160(4):1255-9. PubMed ID: 9751330
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of primary hepatic malignancies in U.S. children.
Darbari A; Sabin KM; Shapiro CN; Schwarz KB
Hepatology; 2003 Sep; 38(3):560-6. PubMed ID: 12939582
[TBL] [Abstract][Full Text] [Related]
11. Association between colorectal cancer and urologic cancers.
Calderwood AH; Huo D; Rubin DT
Arch Intern Med; 2008 May; 168(9):1003-9. PubMed ID: 18474765
[TBL] [Abstract][Full Text] [Related]
12. [Iron storage disease].
Horváth G; Dávid K
Orv Hetil; 2004 Sep; 145(39):1979-84. PubMed ID: 15553908
[TBL] [Abstract][Full Text] [Related]
13. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study.
Card TR; West J; Holmes GK
Aliment Pharmacol Ther; 2004 Oct; 20(7):769-75. PubMed ID: 15379837
[TBL] [Abstract][Full Text] [Related]
14. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
15. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
[TBL] [Abstract][Full Text] [Related]
16. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
17. Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients.
Milman N; Pedersen P; á Steig T; Byg KE; Graudal N; Fenger K
Ann Hematol; 2001 Dec; 80(12):737-44. PubMed ID: 11797115
[TBL] [Abstract][Full Text] [Related]
18. [High incidence of non-AIDS-defined cancers among HIV-infected patients in Germany. A 3-year nationwide review].
Mosthaf FA; Hanhoff NJ; Goetzenich A; Wolf E; Knechten H
Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1849-52. PubMed ID: 16915544
[TBL] [Abstract][Full Text] [Related]
19. Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer.
Abraham BK; Justenhoven C; Pesch B; Harth V; Weirich G; Baisch C; Rabstein S; Ko YD; Brüning T; Fischer HP; Haas S; Brod S; Oberkanins C; Hamann U; Brauch H;
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1102-7. PubMed ID: 15894659
[TBL] [Abstract][Full Text] [Related]
20. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection.
Duberg AS; Nordström M; Törner A; Reichard O; Strauss R; Janzon R; Bäck E; Ekdahl K
Hepatology; 2005 Mar; 41(3):652-9. PubMed ID: 15723449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
